Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma., Mondello, Patrizia, Tadros Saber, Teater Matt, Fontan Lorena, Chang Aaron Y., Jain Neeraj, Yang Haopeng, Singh Shailbala, Ying Hsia-Yuan, Chu Chi-Shuen, et al. , Cancer Discov, 2020 Mar, Volume 10, Issue 3, p.440-459, (2020)

Emerging epigenetic-modulating therapies in lymphoma., Sermer, David, Pasqualucci Laura, Wendel Hans-Guido, Melnick Ari, and Younes Anas , Nat Rev Clin Oncol, 2019 Aug, Volume 16, Issue 8, p.494-507, (2019)